Interview with CEO of SynAct Pharma, a biotech company with two projects in phase II

18 November 2019 - 16:35
SynAct Pharma is a Danish biotech company that will have two projects in phase II in year 2020. To learn more about the company IPOhub has done an interview with CEO Jeppe Øvli Øvlesen....
Spotlight (Sweden)
SynAct Pharma AB
SynAct Pharma is a pharmaceutical group that conducts research and development in the treatment of inflammatory diseases. The company has developed a platform technology that is aimed at severe conditions in chronic inflammatory diseases, and foremost joint injuries. The subsidiary SynAct Pharma Aps was initially founded in 2012 and the parent company was established in 2016. The head office is lo...
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date